Gladstone NOW: The Campaign Join Us on the Journey ✕
751 - 765 of 1429 Results Clear All
While Pride Month cannot be celebrated with the same in-person events, we hope these backgrounds serve as a digital display to honor this month.
The New York Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of the virologists prominently featured in this detailed account of the COVID-19 pandemic and of scientists’ efforts to understand and fight the coronavirus.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
In this episode of the Newton Series, Katie Pollard shares how big data allows for deep exploration of the human microbiome.
Gladstone Experts Data Science and Biotechnology Pollard Lab Big Data Microbiome
San Francisco Chronicle—Wearing a mask is increasingly mandated by businesses and local jurisdictions, but some people have refused to comply. Senior Investigator Warner Greene explains that since the coronavirus is spread by respiratory droplets, a mask is an extremely effective way to reduce transmission.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
Deep Background with Noah Feldman—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, shares the results of his lab's evaluation of currently available antibody tests for SARS-CoV-2 infection.
Gladstone Experts COVID-19 Genomic Immunology Marson Lab
SF Business Times—Melanie Ott, director of the Gladstone Institute of Virology, was recently named one of the most influential women in Bay Area business by the San Francisco Business Times. She reflects on the similarities between the AIDS crisis and the current COVID-19 pandemic, and describes how her lab has refocused their efforts on the novel virus.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
San Francisco Business Times—Early on in the pandemic, Gladstone Senior Investigator Jennifer Doudna, PhD, co-discoverer of CRISPR, recognized the need for safe, reliable, and rapid COVID-19 testing. She quickly mobilized a team of scientists from UC Berkeley, UC San Francisco, and elsewhere to develop a high-throughput detection assay and test vulnerable and at-risk populations in the Bay Area. Doudna was recently named one of the most influential women in Bay Area business by the San Francisco Business Times.
Womens Initiative Gladstone Experts COVID-19 Data Science and Biotechnology Doudna Lab
Alexander Marson leads the charge with the new Gladstone-UCSF Institute of Genomic Immunology
Institutional News Genomic Immunology Marson Lab
Get a deeper look at the most promising COVID-19 projects at Gladstone.
Gladstone Experts COVID-19
San Francisco Chronicle—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, joined other Bay Area women scientists in an editorial on how the coronavirus pandemic has caused disproportionate challenges for women’s careers, and threatens to reinforce long-standing inequities in the STEM fields.
Womens Initiative COVID-19 Pollard Lab
HIV remodels its target cells, facilitating spread from the female reproductive tract to the rest of the body, shows a new study at Gladstone Institutes.
News Release Research (Publication) HIV/AIDS Center for HIV Cure Research Infectious Disease Roan Lab Disease Models Single Cell
San Francisco Chronicle—Senior Investigator Warner Greene comments on how people can reduce risks when resuming get-togethers with friends or family.
Gladstone Experts COVID-19 Greene Lab
In this edition of the Newton Webinar Series, Jeanne Paz shared her lab’s unique approach to understanding the mechanisms of epilepsy and how it could lead to potential treatments.
Gladstone Experts Epilepsy Neurological Disease Paz Lab
When Science Speaks Podcast—Senior Investigator Warner Greene shares his team’s plan to screen FDA-approved drugs to find those that could be repurposed to fight COVID-19.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
The Mercury News—Scientists are racing to develop and test vaccines to protect people against COVID-19, and clinical trials to determine the efficacy of one leading vaccine candidate are scheduled to begin in July. Melanie Ott, director of the Gladstone Institute of Virology, explained that vaccine development is a lengthy process, and the development of effective therapeutics may come before a vaccine is widely available.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
